Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Equine Intestinal Microbiome in Hypersensitivity Disorders

PROVIDER: PRJNA548852 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9302000_1.fastq.gz	Fastqsanger.gz
	SRR9302000_2.fastq.gz	Fastqsanger.gz
	SRR9302010_1.fastq.gz	Fastqsanger.gz
	SRR9302010_2.fastq.gz	Fastqsanger.gz
	SRR9302020_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 280

Similar Datasets

Project description:Reproductive Disorders in Equine

| PRJNA1214833 | ENA

Modulatory role of skin microbiome against UV

Project description:The role of the skin microbiome in UV-induced immune suppression has been overlooked. We addressed the question of microbial involvement in UV-induced immune suppression by using the standard model of contact hypersensitivity in the presence or absence of the microbiome (in germ-free [GF] and disinfected mice) and found that the microbiome inhibits UV-induced immune suppression. Furthermore, our transcriptome analysis (24 hours after irradiation) showed differential regulation of many genes in the presence or absence of the microbiome, including a predominance of pro-inflammatory cytokines versus immunosuppressive cytokines

2019-05-26 | GSE117359 | GEO

Analyses of the chromatin and transcriptional basis for lateral inhibition in isolated intestinal epithelial cells.

Project description:We analyzed chromatin modifications, DNaseI-hypersensitive sites, and occupancy of a key secretory-lineage transcription factor, ATOH1. We found that lateral inhibition in the intestine occurs through ATOH1 exerting direct control within a broadly permissive chromatin state that is established in stem cells and is highly similar in specified progenitors of divergent potential. Mapping chromatin modifications (H3K4me2 and H3K27ac), DNaseI hypersensitivity (DHS), and ATOH1 binding sites in isolated intestinal crypt progenitors and mature intestinal villus cells.

2014-01-06 | E-GEOD-51458 | biostudies-arrayexpress

Project description:Equine Microbiome Project

| PRJNA715971 | ENA

Bacillus amyloliquefaciens strain:Equine intestinal bacteria | isolate:Equine intestinal bacteria

Project description:Bacillus amyloliquefaciens strain:Equine intestinal bacteria | isolate:Equine intestinal bacteria Genome sequencing

| PRJNA903223 | ENA

Bacillus velezensis strain:Equine intestinal bacteria | isolate:Equine intestinal bacteria

Project description:Bacillus velezensis strain:Equine intestinal bacteria | isolate:Equine intestinal bacteria Genome sequencing

| PRJNA903225 | ENA

Effect of dietary tryptophan deficiency on intestinal ileum gene expression

Project description:To investigate the intestinal ileum response to dietary tryptophan deficiency and the contribution of the intestinal microbiome in regulating these responses

2023-02-21 | GSE222818 | GEO

Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine

Project description:Recent evidence has demonstrated that the gut microbiome has marked effects on neuronal function and behavior. Disturbances to microbial populations within the gut have been linked to myriad models of neuropsychiatric disorders. However, the role of the microbiome in substance use disorders remains understudied. Here we show that male mice with their gut microbiome depleted by nonabsorbable antibiotics (Abx) exhibit decreased formation of morphine conditioned place preference across a range of doses (2.5-15 mg/kg), have decreased locomotor sensitization to morphine, and demonstrate marked changes in gene expression within the nucleus accumbens (NAc) in response to high-dose morphine (20 mg/kg × 7 days). Replacement of short-chain fatty acid (SCFA) metabolites, which are reduced by microbiome knockdown, reversed the behavioral and transcriptional effects of microbiome depletion. This identifies SCFA as the crucial mediators of microbiome-brain communication responsible for the effects on morphine reward caused by microbiome knockdown. These studies add important new behavioral, molecular, and mechanistic insight to the role of gut-brain signaling in substance use disorders

2023-05-18 | GSE232836 | GEO

Osteopontin Exacerbates High-Fat Diet-induced Metabolic Disorders in a microbiome-dependent Manner

Project description:Gut microbiota is involved in metabolic disorders. However, microbiome-based therapeutic interventions are not always effective, which might be due to interference of the host factors. Here, we first identified a strong positive correlation between OPN levels and BMI in humans. Next, we confirmed that OPN could aggravate high-fat diet induced metabolic disorders in mice. Importantly, we found that fecal microbiota transplantation from OPN-deficient mice significantly alleviated metabolic disorders in WT mice. OPN directly induces remodeling of the gut microbiota both in vitro and in vivo. These findings indicate that OPN could contribute to metabolic disorders by inducing an alteration of gut microbiota. OPN regulated the relative abundance of Lactobacillus by decreasing the adhesion of Lactobacillus to intestinal epithelial cells through Notch signaling pathway. These data identify OPN may serve as a potential pharmaceutical target for weight control and metabolic disorders treatment.

2022-10-26 | GSE216386 | GEO

Equine kerainocytes in IBH pathogenesis

Project description:Role of keratinocytes in the pathogenesis of equine insect bite hypersensitivity

| PRJEB37568 | ENA